Advances in Preeclampsia: OU Enrolling Patients in Phase 3 Preeclampsia Study
PRESERVE-1 is a Phase 3 clinical study for women who develop preeclampsia between weeks 23-30 of gestation requiring inpatient hospitalization and eligible for expectant management. This study will assess if…
Read More from Advances in Preeclampsia: OU Enrolling Patients in Phase 3 Preeclampsia Study